Pathways leading to suicide in schizophrenia

Current Psychiatry Reviews

Volumn 3, Issue 4, 2007, Pages 233-242

  Alaräisänen, Antti ^a   Heikkinen, Johanna ^a   Kianickova, Zuzana ^a   Miettunen, Jouko ^a   Räsänen, Pirkko ^a   Isohanni, Matti ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Developmental trajectory; Life span; Schizophrenia; Suicide

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; CLOZAPINE; METHIONINE; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG; VALINE;

CLINICAL TRIAL; COMORBIDITY; CONSENSUS; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPHORIA; FAMILY HISTORY; GENETIC POLYMORPHISM; HUMAN; IMPULSIVENESS; INTELLIGENCE; LIFESPAN; PHENOTYPE; PRIORITY JOURNAL; PSYCHOTHERAPY; RELAPSE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL SUPPORT; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; TREATMENT FAILURE;

EID: 36248988609     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340007782408879     Document Type: Review

References (80)

1. Palmer-BA, Pankratz VS, Bostwick JM. The lifetime risk for suicide in schizophrenia: A Re-examination. Arch Gen Psychiatry 2005; 62: 247-53.
2. Hawton K, Sutton L, Haw C, Sinclair J, Decks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry 2005; 187: 9-20.
3. Isohanni M, Miettunen J, Mäki P, et al. Risk factors for schizophrenia. Follow-up data from the northern Finland 1966. World Psychiatry 2006; 5: 168-71.
4. Mäki P, Veijola J, Jones PB, et al. Predictors of schizophrenia - a review. Br Med Bull 2005; 73-74: 1-15.
5. Sullivan P. The genetics of schizophrenia. PLoS Med 2005; 2: e212.
6. De Leo D, Spathonis K. Do Psychosocial and Pharmacological Interventions Reduce Suicide in Schizophrenia and Schizophrenia Spectrum Disorders? Arch Suicide Res 2003; 7: 353-74.
7. Heilä H, Lönnqvist J. In: Murray R, Jones P, Susser E, van Os J, Cannon M Eds, Epidemiology of schizophrenia, Cambridge University Press. 2003; 288-316.
8. Marčinko D, Marčinko A, Slijepčević M. Suicide in schizophrenia: Risk factors, therapy and preventive strategies. Psychiatr Danub 2003; 15: 201-7.
9. Lewis L. Mourning, insight and reduction of suicide risk in schizophrenia. Bull Menninger Clin 2004; 68: 231-44.
10. Pompili M, Ruberto A, Kotzalidis G, Girardi P, Tatarelli R. Suicide and awareness of illness in schizophrenia: an overview. Bull Menninger Clin 2004; 68: 297-318.
11. Pompili M, Girardi P, Ruberto A, Titarelli R. Toward a new prevention of suicide in schizophrenia World J Biol Psychiatry 2004; 5: 201-10.
12. Haw C, Hawton K, Sutton L, Sinclair J, Decks J. Schizophrenia and Deliberate Self-Harm: A Systematic Review of Risk Factors. Suicide Life Threat Behav 2005; 35: 50-62.
13. Montross L, Zisook S, Kasckow J. Suicide Among Patients with Schizophrenia: A Consideration of Risk and Protective Factors. Ann Clin Psychiatry 2005; 17: 173-82.
14. Perenyi A, Forlano R. Suicide in schizophpenia. Neuropsychopharmacol Hung 2005; 7: 107-17.
15. Pompili M, Mancinelli I, Ruberto A, Kotzalidis GD, Gerardi P, Tatarelli R. Where schizophrenic patients commit suicide: a review of suicide among inpatients and former inpatients. Int J Psychiatry Med 2005; 35: 171-90.
16. Pompili M, Amador X F, Girardi P, et al. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry 2007; 6: 10. doi: 10.1186/1744-859X-6-10
17. The International Handbook of Suicide and Attempted Suicide. Hawton K, van Heeringen K (eds). West Sussex, John Wiley & Sons 2000.
18. Suicide in Schizophrenia. Tatarelli R, Pompili M, Girardi P (eds). New York. Nova Science Publishers 2006.
19. Bayle F, Leroy S, Gourion D, et al. 5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attempts. Am J Med Genet B Neuropsychiatr Genet 2003; 119: 13-7.
20. Campi-Azevedo AC, Boson W, De Marco L, Romano-Silva MA, Correa H. Association of the serotonin transporter promoter polymorphism with suicidal behavior. Mol Psychiatry 2003; 8: 899-900.
21. Ertugrul A, Kennedy J, Masellis M, Basile VS, Jayathilake K, Meltzer HY. No association of the T102C polymorphisin of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia. Schizophr Res 2004; 69: 301-5.
22. Han DH, Park D, Na C, Kee BS, Lee YS. Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes. Psychiatry Res 2004; 129: 29-37.
23. Hong C-J, Pan G-M, Tsai S-J. Association Study of Onset Age, Attempted Suicide, Aggressive Behavior, and Schizophrenia with a Serotonin 1B Receptor (A-161T) Genetic Polymorphism. Neuropsychobiology 2004; 49: 1-4.
24. De Luca V, Zai G, Tharmalingam S, de Bartolomeis A, Wong G, Kennedy JL. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia. Eur Neuropsychopharmacol 2006; 16: 268-71.
25. De Luca V, Tharmalingam S, Müller D, Wong G, de Bartolomeis A, Kennedy JL. Gene-gene interaction between MAOA and COMT in suicidal behavior: Analysis in schizophrenia. Brain Res 2006; 1097: 26-30.
26. De Luca V, Hlousek D, Likhodi O, van Tol HH, Kennedy JL, Wong AH. The interaction between TPH2 promoter haplotypes and clinical-demographic risk factors in suicide victims with major psychoses. Genes Brain Behav 2006; 5: 107-10.
27. De Luca V, Likhodi O, Kennedy JL, Wong AH. Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism: Analysis of suicidality in schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2007; 12: 370-4.
28. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand 2003; 108: 208-14.
29. Huang T, Lee C. Associations between serum brain-derived neurotrophic factor fevels and clinicalphenotypes in schizophrenia patients. J Psychiatr Res 2006; 40: 664-8.
30. Schwartz R, Smith S. Suicidality and psychosis: The predictive potential of symptomatology and insight into illness. J Psychiatr Res 2003; 38: 185-91.
31. Kim CH, Jayathilake K, Meltzer H. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr Res 2003; 60: 71-80.
32. Bourgeois M, Swendsen J, Young F, et al. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. Am J Psychiatry 2004; 161: 1494-6.
33. Crumlish N, Whitty P, Kamali M, et al. Early insight predicts depression and attempted suicide after 4 years infirst-episode schizophrenia and schizophreniform disorder. Acta Psychiatr Scand 2005; 112: 449-55.
34. Saarinen PI, Lehtonen J, Lonnqvist J. Suicide Risk in Schizophrenia: An analysis of 17 Consecutive Suicides. Schizophr Bull 1999; 25: 533-42.
35. Aguilar E, Leal C, Acosta F, Cejas MR, Fernandez R, Gracia R. A psychopathological study of a group of schizophrenic patients after attempting suicide. Are there two different clinical subtypes?. Eur Psychiatry 2003; 18: 190-2.
36. Kua J, Wong KE, Kua EH, Tsoi WF. A 20-year follow-up study on schizophrenia in Singapore. Acta Psychiatr Scand 2003; 108: 118-25.
37. Malone K, Waternaux C, Haas G, Cooper TB, US, Mann JJ. Cigarette smoking, suicidal behivior, and serotonin function in major psychiatric disorders. Am J Psychiatry 2003; 160: 773-9.
38. Potkin S, Alpha L, Hsu C, et al. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol Psychiatry 2003; 54: 444-5Z.
39. Baca-Garcia E, Perez-Rodriguez MM, Diaz Sastre C, Saiz-Ruiz J, de Leon J. Suicidal behavior in schizopbrenia and depression: a comparison. Schizophr Res 2005; 75(1): 77-81.
40. Evren C, Evren B. Characteristics of schizophrenic patients with a history of suicide attempt. Int J Psychiatry Clin Prac 2004; 8: 227-34.
41. Kelly D, Shim J-C, Feldman S, Yu Y, Conley RR. Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res 2004; 38: 531-6.
42. Sinclair J, Mullee M, King E, Baldwin DS. Suicide in Schizophrenia: A Retrospective Case-Control Study of 51 Suicides. Schizophr Bull 2004; 30: 803-11.
43. Dong J, Ho T, Kan C. A case-control study of 92 cases of in-patient suicides. J Affect Disord 2005; 87: 91-9.
44. Fennig S, Horesh N, Aloni D, Apter A, Weizman A, Fermig S. Life events and suicidality in adolescents with schizophrenia. Eur Child Adolesc Psychiatry 2005; 14: 454-60.
45. Kuo CJ, Tsai SY, Lo CH, Wang YP, Chen CC. Risk factors for completed suicide in schizophrenia. J Clin Psychiatry 2005; 66: 579-85.
46. Roy A. Reported Childhood Trauma and Suicide Attempts in Schizophrenic Patients. Suicide Life Threat Behav 2005; 35: 690-3.
47. Tidemalm D, Elofsson S, Stefansson C, Waern M, Runeson B. Predictors of suicide in a community-based cohort of individuals with severe mental disorder. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 595-600.
48. Trémeau F, Staner L, Duval F, et al. Suicide Attempts and Family History of Suicide in Three Psychiatric Populations. Suicide Life Threat Behav 2005; 35: 702-13.
49. Acosta F, Aguilar E, Cejas MR, Gracia R, Caballero-Hidalgo A, Siris SG. Are there subtypes of suicidal schizophrenia? A prospective study. Schizophr Res 2006; 86: 215-20.
50. Hunt IM, Kapur N, Windfuhr K, et al. National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. Suicide in schizophrenia: findings from a national clinical survey. J Psychiatr Pract 2006; 12: 139-47.
51. Kaneda Y. Suicidality in schizophrenia as a separate symptom domain that may be independent of depression or psychosis. Schizophr Res 2006; 81: 113-4.
52. Alaräisänen A, Miettunen J, Lauronen E, Räsäncn P, Isohanni M. Good school performance is a risk factor of suicide in psychoses. A 35-year follow-up of the Northern Finland 1966 Birth Cohort. Acta Psychiatr Scand 2006; 114: 357-62.
53. McGirr A, Tousiguant M, Routhier D, et al. Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders: A case-control study. Schizophr Res 2006; 84: 132-43.
54. Li D, Duan Y, He L. Association study of serutonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 2006; 340: 1006-15.
55. Bondy B, Buettner A, Zill P. Genetics of suicide. Mol Psychiatry 2006; 11: 336-51.
56. Li D, He L. Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analysis. Hum Genet 2006; 119: 233-40.
57. Pezawas L, Meyer-Lindenberg A, Drabant EM, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-34.
58. Helbecque N, Sparks DL, Hunsaker JC 3rd, Amouyel P. The serotonin transporter promoter polymorphism and suicide. Neurosci Lett 2006; 400: 13-5.
59. Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K. Association between catechol-O-methyltransferase functional polyomrphism and male suicide completers. Neuropsychopharmacology 2004; 29: 1374-7.
60. Yanagi M, Shirakawa O, Kitamura N, et al. Association of 14-3-3 epsilon gene haplotype with completed suicide in Japanese. J Hum Genet 2005; 50: 210-6.
61. Online Mendelian Inheritance in Man, OMIM ™. MsKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 3/6/2007. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/
62. De Hert M, McKennzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res 2001; 47: 127-34.
63. Brent DA, Mann JJ. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005; 133: 13-24.
64. Fenton WS. Depression, suicide, and suicide prevention in schizophrenia. Suicide Life Threat Behav 2000; 30: 34-49.
65. Farberow NL, Shneidman ES, Neuringer C. Case history and hospitalization factors in suicides of neuropsychiatric hospital patients. J Nerv Ment Dis 1966; 142: 32-44.
66. Sletten IW, Brown ML, Evenson RC, Altman H. Suicide in mental hospital patients. Dis Nerv Syst 1972; 33: 328-34.
67. Drake RE, Gates C, Cotton PG, Whitaker A. Suicide among schizophrenics. Who is at risk? J Nerv Ment Dis 1984; 172: 613-17.
68. Dingman C, McGlashan T. Discriminating characteristics of suicides: Chestnut Lodge follow-up sample including patients with affective disorder, schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 1986; 74: 91-7.
69. Apter A, Bleich A, King RA, et al. Death without warning? A clinical postmortem study of suicide in 43 Israeli adolescent males. Arch Gen Psychiatry 1993; 50: 138-42.
70. Birchwood M, Iqbal Z, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis: I. Ontogeny of post-psychotic depression. Br J Psychiatry 2000; 177: 516-28.
71. Heila H, Isometsa ET, Henriksson MM, et al. Suicide and schizopbrenia. Am J Psychiatry 1997; 154: 1235-42.
72. Addington DD, Azorin JM, Falloon IRH, et al. Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatr Scand 2002; 105: 189-95.
73. Schwirtz-Stav O, Apter A, Zalsman G. Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur Child Adolesc Psychiatry 2006; 15: 352-9.
74. Mak W, Wu C. Cognitive Insight and Causal Attribution in the Development of Self-Stigma Among Individuals With Schizophrenia. Psychiatr Serv 2006; 57: 1800-2.
75. Pompili.K Mancinelli I, Tatarelli R. Stigma as acause of suicide. Br J Psychiatry 2003; 183: 173-4.
76. Gottesman II, Gould TD. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-45.
77. Savitz JB, Cupido CL, Ramesar RS. Trends in Suicidology: Personality as an Endophenotype for Molecular Genetic Investigations. PLoS Med 2006; 3: 0619-23.
78. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci 2006; 103: 6269-74.
79. Egan NY, Goldberg TE, Kolachana BS, et al. Effect of COMT val(108/ 158)met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci 2001; 98: 6917-22.
80. Tiihonen J, Walhbeck K, Lonnqvist J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006;, 333: 224. doi:10.1136/bmj.38881.382155.2F (published 6 July 2006).